Filing Details
- Accession Number:
- 0001615774-18-005289
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-14 16:05:43
- Reporting Period:
- 2018-06-14
- Accepted Time:
- 2018-06-14 16:05:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1430306 | Tonix Pharmaceuticals Holding Corp. | TNXP | Pharmaceutical Preparations (2834) | 261434750 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1668150 | Bradley Saenger | C/O Tonix Pharmaceuticals Holding Corp. 509 Madison Avenue, Suite 306 New York NY 10022 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value | Acquisiton | 2018-06-14 | 300 | $4.10 | 3,079 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
